APA (7th ed.) Citation

Chiha, W., Bartlett, C., Petratos, S., Fitzgerald, M., & Harvey, A. (2020). Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury. ACADEMIC PRESS INC ELSEVIER SCIENCE.

Chicago Style (17th ed.) Citation

Chiha, Wissam, C.A Bartlett, S. Petratos, Melinda Fitzgerald, and A.R Harvey. Intravitreal Application of AAV-BDNF or Mutant AAV-CRMP2 Protects Retinal Ganglion Cells and Stabilizes Axons and Myelin After Partial Optic Nerve Injury. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2020.

MLA (9th ed.) Citation

Chiha, Wissam, et al. Intravitreal Application of AAV-BDNF or Mutant AAV-CRMP2 Protects Retinal Ganglion Cells and Stabilizes Axons and Myelin After Partial Optic Nerve Injury. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2020.